These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 27623948)

  • 1. An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
    van de Bunt M
    Diabetologia; 2016 Nov; 59(11):2292-2294. PubMed ID: 27623948
    [No Abstract]   [Full Text] [Related]  

  • 2. TCF7L2: the biggest story in diabetes genetics since HLA?
    Zeggini E; McCarthy MI
    Diabetologia; 2007 Jan; 50(1):1-4. PubMed ID: 17096114
    [No Abstract]   [Full Text] [Related]  

  • 3. The TCF7L2 locus and type 1 diabetes.
    Qu HQ; Polychronakos C
    BMC Med Genet; 2007 Aug; 8():51. PubMed ID: 17683561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
    Jin T; Liu L
    Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TCF7L2 and type 2 diabetes--we WNT to know.
    Smith U
    Diabetologia; 2007 Jan; 50(1):5-7. PubMed ID: 17102948
    [No Abstract]   [Full Text] [Related]  

  • 6. Translating TCF7L2: from gene to function.
    Pearson ER
    Diabetologia; 2009 Jul; 52(7):1227-30. PubMed ID: 19387612
    [No Abstract]   [Full Text] [Related]  

  • 7. Overlap of genetic susceptibility to type 1 diabetes, type 2 diabetes, and latent autoimmune diabetes in adults.
    Basile KJ; Guy VC; Schwartz S; Grant SF
    Curr Diab Rep; 2014; 14(11):550. PubMed ID: 25189437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample.
    Scott LJ; Bonnycastle LL; Willer CJ; Sprau AG; Jackson AU; Narisu N; Duren WL; Chines PS; Stringham HM; Erdos MR; Valle TT; Tuomilehto J; Bergman RN; Mohlke KL; Collins FS; Boehnke M
    Diabetes; 2006 Sep; 55(9):2649-53. PubMed ID: 16936217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function.
    Gloyn AL; Braun M; Rorsman P
    Diabetes; 2009 Apr; 58(4):800-2. PubMed ID: 19336690
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects.
    Field SF; Howson JM; Smyth DJ; Walker NM; Dunger DB; Todd JA
    Diabetologia; 2007 Jan; 50(1):212-3. PubMed ID: 17063324
    [No Abstract]   [Full Text] [Related]  

  • 11. The new type 2 diabetes gene TCF7L2.
    Florez JC
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):391-6. PubMed ID: 17563454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2.
    Wilkin TJ
    Diabetologia; 2007 Aug; 50(8):1780. PubMed ID: 17589824
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort.
    van Vliet-Ostaptchouk JV; Shiri-Sverdlov R; Zhernakova A; Strengman E; van Haeften TW; Hofker MH; Wijmenga C
    Diabetologia; 2007 Jan; 50(1):59-62. PubMed ID: 17031610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of TCF7L2.
    Weedon MN
    Diabet Med; 2007 Oct; 24(10):1062-6. PubMed ID: 17888129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population.
    Horikoshi M; Hara K; Ito C; Nagai R; Froguel P; Kadowaki T
    Diabetologia; 2007 Apr; 50(4):747-51. PubMed ID: 17245589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The
    Grant SFA
    Diabetes Care; 2019 Sep; 42(9):1624-1629. PubMed ID: 31409726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
    Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
    Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?
    Adams JD; Vella A
    Metab Syndr Relat Disord; 2018 Oct; 16(8):383-389. PubMed ID: 29993315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels.
    Kimber CH; Doney AS; Pearson ER; McCarthy MI; Hattersley AT; Leese GP; Morris AD; Palmer CN
    Diabetologia; 2007 Jun; 50(6):1186-91. PubMed ID: 17429603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor 7-like 2 (TCF7L2) gene polymorphism rs7903146 is associated with stroke in type 2 diabetes patients with long disease duration.
    Choi HJ; Lee DH; Jeon HJ; Kim DS; Lee YH; Oh T
    Diabetes Res Clin Pract; 2014 Mar; 103(3):e3-6. PubMed ID: 24529562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.